• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Notch 通路抑制显著降低横纹肌肉瘤的体外侵袭性和迁移能力。

Notch pathway inhibition significantly reduces rhabdomyosarcoma invasiveness and mobility in vitro.

机构信息

Biomedical Research Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

出版信息

Clin Cancer Res. 2011 Feb 1;17(3):505-13. doi: 10.1158/1078-0432.CCR-10-0166. Epub 2010 Dec 21.

DOI:10.1158/1078-0432.CCR-10-0166
PMID:21177409
Abstract

PURPOSE

Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children and can be divided into two main subtypes: embryonal and alveolar RMS. Patients with metastatic disease continue to have very poor prognosis although aggressive therapies and recurrences are common in advanced localized disease. The oncogenic potential of the Notch pathway has been established in some cancers of the adult and in some pediatric malignancies.

EXPERIMENTAL DESIGN

A real-time PCR assay was used to ascertain the expression of several Notch pathway components in a wide panel of RMS and cell lines. Four γ-secretase inhibitors (GSIs) were tested for pathway inhibition and the degree of inhibition was assessed by analysis of Hes1 and Hey1 expression. The putative effects of Notch pathway inhibition were evaluated by wound-healing, matrigel/transwell invasion, cell-cycle, and apoptosis assays.

RESULTS

The Notch pathway was widely expressed and activated in RMS and underwent substantial inhibition when treated with GSIs or transfected with a dominant negative form of MAML1. RMS cells showed a significant decrease in its mobility and invasiveness when the Notch pathway was properly inhibited; conversely, its inhibition had no noticeable effect on cell cycle or apoptosis.

CONCLUSION

Pharmacological or genetic blockage of the pathway significantly reduced invasiveness of RMS cell lines, thereby suggesting a possible role of the Notch pathway in the regulation of the metastatic process in RMS.

摘要

目的

横纹肌肉瘤(RMS)是儿童中最常见的软组织肉瘤类型,可分为两个主要亚型:胚胎性和肺泡性 RMS。尽管转移性疾病患者的预后仍然非常差,但即使在晚期局限性疾病中也经常出现侵袭性治疗和复发。Notch 通路的致癌潜能已在一些成人癌症和一些儿科恶性肿瘤中得到证实。

实验设计

使用实时 PCR 分析确定了 Notch 通路的几个成分在广泛的 RMS 和细胞系中的表达。测试了四种 γ-分泌酶抑制剂(GSIs)以抑制通路,并通过分析 Hes1 和 Hey1 的表达来评估抑制程度。通过划痕愈合、基质胶/Transwell 侵袭、细胞周期和凋亡测定评估 Notch 通路抑制的潜在作用。

结果

Notch 通路在 RMS 中广泛表达并被激活,当用 GSIs 处理或转染显性负形式的 MAML1 时,它受到显著抑制。当 Notch 通路被适当抑制时,RMS 细胞的迁移和侵袭能力显著下降;相反,其抑制对细胞周期或凋亡没有明显影响。

结论

该通路的药理学或遗传阻断显著降低了 RMS 细胞系的侵袭性,这表明 Notch 通路在 RMS 转移过程的调节中可能发挥作用。

相似文献

1
Notch pathway inhibition significantly reduces rhabdomyosarcoma invasiveness and mobility in vitro.Notch 通路抑制显著降低横纹肌肉瘤的体外侵袭性和迁移能力。
Clin Cancer Res. 2011 Feb 1;17(3):505-13. doi: 10.1158/1078-0432.CCR-10-0166. Epub 2010 Dec 21.
2
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling.Notch信号通路药理抑制诱导细胞周期停滞后T细胞急性淋巴细胞白血病细胞中的凋亡
Chem Biol. 2007 Feb;14(2):209-19. doi: 10.1016/j.chembiol.2006.12.010.
3
Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.Notch信号通路抑制可耗尽胚胎性脑肿瘤中的干细胞样细胞并阻断其植入。
Cancer Res. 2006 Aug 1;66(15):7445-52. doi: 10.1158/0008-5472.CAN-06-0858.
4
Notch-mediated induction of N-cadherin and α9-integrin confers higher invasive phenotype on rhabdomyosarcoma cells.Notch 介导的 N-钙黏蛋白和 α9 整合素的诱导赋予横纹肌肉瘤细胞更高的侵袭表型。
Br J Cancer. 2012 Oct 9;107(8):1374-83. doi: 10.1038/bjc.2012.411. Epub 2012 Sep 13.
5
Gamma-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells.γ-分泌酶抑制剂通过下调人舌癌细胞中的Notch和核因子κB发挥抗肿瘤活性。
Oral Dis. 2007 Nov;13(6):555-63. doi: 10.1111/j.1601-0825.2006.01334.x.
6
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.γ-分泌酶抑制剂下调 Notch 通路可抑制 ERBB2 转基因乳腺癌模型中的 AKT/哺乳动物雷帕霉素靶蛋白信号通路和葡萄糖摄取。
Cancer Res. 2010 Mar 15;70(6):2476-84. doi: 10.1158/0008-5472.CAN-09-3114. Epub 2010 Mar 2.
7
Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group.转移性和复发性横纹肌肉瘤患者能否从造血干细胞救援的大剂量治疗中获益?德国/奥地利儿科骨髓移植组的报告。
Bone Marrow Transplant. 1997 Feb;19(3):227-31. doi: 10.1038/sj.bmt.1700628.
8
Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.抑制 Notch 信号通路减少乳腺癌细胞的干细胞样群体并阻止乳腺球形成。
Anticancer Res. 2010 Oct;30(10):3853-67.
9
Inhibition of gamma-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling.γ-分泌酶的抑制通过Notch信号通路影响白血病和肝癌细胞系的增殖。
Anticancer Drugs. 2008 Jun;19(5):477-86. doi: 10.1097/CAD.0b013e3282fc6cdd.
10
[Rhabdomyosarcoma lysis by T cells expressing a human autoantibody based chimeric receptor targeting the fetal acetylcholine receptors].[通过表达靶向胎儿乙酰胆碱受体的基于人自身抗体的嵌合受体的T细胞溶解横纹肌肉瘤]
Verh Dtsch Ges Pathol. 2006;90:264-76.

引用本文的文献

1
MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.MET抑制使横纹肌肉瘤细胞对NOTCH信号抑制敏感。
Front Oncol. 2022 Apr 27;12:835642. doi: 10.3389/fonc.2022.835642. eCollection 2022.
2
The Extracellular Matrix in Soft Tissue Sarcomas: Pathobiology and Cellular Signalling.软组织肉瘤中的细胞外基质:病理生物学与细胞信号传导
Front Cell Dev Biol. 2021 Dec 9;9:763640. doi: 10.3389/fcell.2021.763640. eCollection 2021.
3
Genomic Analysis Revealed Mutational Traits Associated with Clinical Outcomes in Osteosarcoma.
基因组分析揭示了骨肉瘤中与临床结果相关的突变特征。
Cancer Manag Res. 2021 Jun 28;13:5101-5111. doi: 10.2147/CMAR.S317809. eCollection 2021.
4
Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.靶向人黏液表皮样癌中的 Notch 和 EGFR 信号通路。
Signal Transduct Target Ther. 2021 Jan 21;6(1):27. doi: 10.1038/s41392-020-00388-0.
5
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.单细胞 RNA 测序揭示原发性眼葡萄膜黑素瘤中的肿瘤内异质性,并鉴定出 HES6 是转移性疾病的驱动基因。
Cell Death Differ. 2021 Jun;28(6):1990-2000. doi: 10.1038/s41418-020-00730-7. Epub 2021 Jan 18.
6
Identification of tumorigenicity-associated genes in osteosarcoma cell lines based on bioinformatic analysis and experimental validation.基于生物信息学分析和实验验证鉴定骨肉瘤细胞系中与致瘤性相关的基因
J Cancer. 2020 Mar 26;11(12):3623-3633. doi: 10.7150/jca.37393. eCollection 2020.
7
Comparison of cachectic and non-cachectic sarcoma patients reveals an important role of Notch signaling in metastasis and myogenesis.恶病质和非恶病质肉瘤患者的比较揭示了Notch信号通路在转移和肌生成中的重要作用。
Am J Cancer Res. 2019 Aug 1;9(8):1746-1756. eCollection 2019.
8
Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeutics.横纹肌肉瘤中的遗传学、表观遗传学和氧化还原稳态:新兴靶点和治疗方法。
Redox Biol. 2019 Jul;25:101124. doi: 10.1016/j.redox.2019.101124. Epub 2019 Jan 25.
9
Soft Tissue Sarcoma Cancer Stem Cells: An Overview.软组织肉瘤癌症干细胞:概述
Front Oncol. 2018 Oct 26;8:475. doi: 10.3389/fonc.2018.00475. eCollection 2018.
10
A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.一种新型 Notch-YAP 通路驱动胚胎性横纹肌肉瘤的干性和肿瘤发生。
Mol Cancer Res. 2017 Dec;15(12):1777-1791. doi: 10.1158/1541-7786.MCR-17-0004. Epub 2017 Sep 18.